Related Experiment Video
Updated: Jun 16, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Major depression during interferon-alpha treatment: vulnerability and prevention.
1Western Psychiatric Institute and Clinic, 3811 O'Hara Street, Pittsburgh, PA 15213, USA. lotrichfe@upmc.edu
Dialogues in Clinical Neuroscience
|February 9, 2010
Summary
Interferon-induced depression (IFN-MDD) affects 15-40% of patients. Prophylactic antidepressants and personalized prevention strategies targeting sleep, inflammation, genetics, personality, and social support can mitigate risks.
Area of Science:
- Neuroscience
- Psychiatry
- Immunology
Background:
- Major Depressive Disorder (MDD) is a potential side effect of interferon-alpha (IFN-alpha) therapy, known as IFN-MDD.
- While most patients tolerate IFN-alpha, 15-40% experience IFN-MDD, sharing characteristics with other MDD forms.
Purpose of the Study:
- To explore the efficacy of prophylactic antidepressants for preventing IFN-MDD.
- To identify predictive markers for IFN-MDD vulnerability in patients commencing IFN-alpha therapy.
Main Methods:
- Review of studies utilizing antidepressants for IFN-MDD prevention.
- Assessment of pre-treatment factors including sleep quality, inflammatory cytokines, serotonin genetic polymorphisms, personality traits, and social support.
Main Results:
- Prophylactic antidepressants appear beneficial for patients with prior MDD or subthreshold depressive symptoms.
- Pre-treatment factors like poor sleep, elevated inflammatory cytokines, specific genetic markers, personality, and low social support are implicated as IFN-MDD risk indicators.
Conclusions:
- Personalized prevention strategies for IFN-MDD are feasible by targeting identified modifiable risk factors.
- Understanding the interplay of biological and psychosocial factors is crucial for predicting and preventing IFN-MDD.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:03Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...